[Biological therapeutic agents and patient autonomy in dermatologic therapy. The Danish Society of Dermatology].
Bygum
Anette
A
Dermatologisk Afdeling I, Odense Universitetshospital, DK-5000 Odense C. anette.bygum@ouh.fyns-amt.dk
Jemec
Gregor B
GB
D000077944:Alefacept; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D003718:Denmark; D003879:Dermatologic Agents / Q000627:therapeutic use*; D000068800:Etanercept; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use; D000069285:Infliximab; D028701:Patient Rights; D026684:Personal Autonomy; D011565:Psoriasis / Q000188:drug therapy / Q000523:psychology / Q000628:therapy*; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use*; D012955:Societies, Medical
D000911:Antibodies, Monoclonal; D003879:Dermatologic Agents; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D011993:Recombinant Fusion Proteins; D000069285:Infliximab; D000077944:Alefacept; D000068800:Etanercept